Regeneron Pharmaceuticals (REGN)
Regeneron Pharmaceuticals (REGN) has reported earnings 89 times since Oct 28, 2004. The stock moves an average of ±3.64% the day after reporting, closing higher 58.4% of the time. Its largest post-earnings gain was +12.31% (Feb 13, 2012) and its largest decline was -9.17% (Oct 31, 2024). The next earnings report is predicted for 2026-10-20 (estimated).
Earnings reactions
How REGN moved on each past earnings report.
Earnings Impact
Total Earnings
89
Avg Abs. Movement
±3.64%
Positive %
58.4%
Negative %
41.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jul 30, 2026 | ☀ PRE | +6.02% | open_in_new |
| Jul 06, 2026 | ☀ PRE | -0.7% | open_in_new |
| Apr 29, 2026 | ☀ PRE | -6.21% | open_in_new |
| Jan 30, 2026 | ☀ PRE | -1.07% | open_in_new |
Earnings Count
89
Total earnings in dataset
Avg Abs. Movement
±3.64%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260903 | open_in_new SEC.gov |
| 4 | 20260903 | open_in_new SEC.gov |
| 4 | 20260903 | open_in_new SEC.gov |
| 144 | 20260902 | open_in_new SEC.gov |
| 144 | 20260902 | open_in_new SEC.gov |
| 4 | 20260821 | open_in_new SEC.gov |
| 4 | 20260820 | open_in_new SEC.gov |
| N-PX | 20260820 | open_in_new SEC.gov |
| 4 | 20260812 | open_in_new SEC.gov |
| 4 | 20260812 | open_in_new SEC.gov |
Frequently asked about REGN earnings
When does Regeneron Pharmaceuticals report earnings next? expand_more
Regeneron Pharmaceuticals (REGN)'s next earnings date is estimated for 2026-10-20. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does REGN stock move after earnings? expand_more
Over 89 reports, REGN has moved an average of ±3.64% the session after earnings, closing higher 58.4% of the time.
What was REGN's biggest post-earnings move? expand_more
REGN's largest post-earnings gain on record was +12.31% on Feb 13, 2012, and its largest decline was -9.17% on Oct 31, 2024.
Where can I find Regeneron Pharmaceuticals's SEC filings? expand_more
All of Regeneron Pharmaceuticals's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Agilent Technologies (A) earnings history chevron_right
- AbbVie (ABBV) earnings history chevron_right
- Abbott Laboratories (ABT) earnings history chevron_right
- Align Technology (ALGN) earnings history chevron_right
- Amgen (AMGN) earnings history chevron_right
- Baxter International (BAX) earnings history chevron_right
- Becton Dickinson (BDX) earnings history chevron_right
- Biogen (BIIB) earnings history chevron_right
- Bristol Myers Squibb (BMY) earnings history chevron_right
- Boston Scientific (BSX) earnings history chevron_right